China NMPA Product Recall - Anti-inflammatory and analgesic magnetic therapy patch

Anhui Zhongkang Pharmaceutical Co., Ltd. initiated a voluntary Level III recall of its anti-inflammatory and analgesic magnetic therapy patch, with the recall officially reported on February 10, 2022. The company's decision stems from the identification of potential quality issues with the medical device. This action was taken under the regulatory oversight of the Anhui Provincial Drug Administration, which operates within the broader National Medical Products Administration (NMPA) framework for medical device compliance in China. A Level III recall indicates that the use of or exposure to the affected product is not likely to cause adverse health consequences. The company's required actions include recalling specific models, specifications, and batch numbers, which are detailed in the